Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis. Vukusic S, Durand-Dubief F, Benoit A, Marignier R, Frangoulis B, Confavreux C Mult Scler. 2014 Oct 10. PMID: 25305253. Abstract CommentRecommendBookmarkWatch